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To the Editor: Ischemic ST-segment changes during atrial fibril-
lation (AF) are a common electrocardiographic finding in patients
with acute coronary syndromes (1) or structural heart disease.
However, not uncommonly, subjects free of apparent heart disease
present with ischemic ST-segment depression during an episode of
AF, out of the setting of an acute cardiopulmonary syndrome.
Although clinicians often consider this clinical presentation to be
a “positive stress-test equivalent,” its relationship with occult
coronary artery disease (CAD) is currently unknown. In this
prospective study we estimated, by coronary angiography, the
prevalence of CAD in otherwise “healthy” individuals who
exhibit ischemic changes during paroxysms of AF but not
during sinus rhythm (SR). Furthermore, we evaluated the
accuracy of 3 commonly used myocardial stress tests (treadmill
electrocardiographic stress-test [TST], thallium-201 myocar-
dial perfusion scintigraphy [MPS], and myocardial contrast
dobutamine stress echocardiography [MCDSE]) to diagnose
CAD in these patients.
Between January 2001 and July 2005, we screened more than
2,500 patients older than 40 years who presented to the emergency
department with AF of recent onset (paroxysmal AF or persistent
AF with duration 30 days) and concomitant ischemic ST-
segment depression. Ischemic ST-segment changes were defined
according to exercise testing standards (2). Patients with a
history of CAD, other cardiac disorders, or severe comorbidities
were excluded from the study. Those who had biochemical
and/or echocardiographic findings indicating an acute cardio-
pulmonary event or structural heart disorder were also excluded
(Fig. 1). Hospital admission was suggested to the remaining
407 patients who comprised the target group of our study.
Conversion to SR was attempted in all admitted patients, either
pharmaceutically or by synchronized transthoracic cardiover-
sion, unless AF terminated spontaneously. Cardioverted pa-
tients with persistent ST-segment depression of more than 48 h
and patients in whom cardioversion was unsuccessful were
excluded (Fig. 1).
Patients who fulfilled all entry criteria and consented to the
study protocol were evaluated both by coronary angiography and
by all 3 stress tests (TST, MPS, and MCDSE) in a random order.
Obstructive CAD was defined as a stenosis 70% in at least 1
epicardial coronary artery. All stress tests were performed accord-
ing to standard protocols (2–4), within a period of 2 weeks to 3
months after SR had been restored. Patients unable to exercise
underwent only dipyridamole MPS and MCDSE. The physicians
who performed the diagnostic tests were blinded to the findings of
other examinations. The study protocol was approved by our
institutional research ethics committee.
Obstructive CAD was documented by angiography in 27 (15
men, 12 women) of the 83 patients who completed the study (Fig.
1), corresponding to a prevalence of 32.5%. Nineteen of these
patients had 1-vessel disease (9 patients had stenosis of the right
coronary artery, 6 of the circumflex, and 4 of the left anterior
descending artery), 5 patients had 2-vessel disease, and 3 patients
had 3-vessel disease. One patient with 2-vessel disease also had a
70% stenosis of the left main coronary artery.
Patients with CAD were marginally older (67.4  7.6 years
vs. 63.8  8.5 years, p  0.06 by Student t test) and had a
higher prevalence of smoking (59% vs. 23%, p  0.001 by
chi-square test) compared to patients without CAD. The
male/female ratio (15/12 vs. 27/29), the prevalence of other
classical risk factors, and the mean heart rate at presentation
(131  17 beats/min vs. 129  19 beats/min) did not differ
between the 2 groups (all p  NS).
Among the 24 patients with CAD who underwent all 3 stress
tests (3 patients with CAD were unable to exercise), 15 patients
had positive results on all 3 tests, 7 patients had 2 positive tests,
and in 1 patient, only MCDSE was positive. Interestingly, all 3
tests were negative in 1 patient with a stenosis of the marginal
branch of the circumflex artery.
Overall, TST had low sensitivity and specificity for CAD
diagnosis. Myocardial perfusion scintigraphy and MCDSE had a
higher sensitivity that corresponded to a relatively high negative
predictive value (Table 1). Myocardial perfusion scintigraphy and
MCDSE misdiagnosed 4 and 3 patients with CAD, respectively.
All these patients had 1-vessel disease confined to relatively small
branches (marginal branch in 2 patients, diagonal branch in 1
patient, and nondominant right coronary artery in 1 patient).
However, MPS exhibited low specificity and a respective low
positive predictive value (Table 1). The majority of the false
positive perfusion defects were located on the posterolateral,
posterior basal, and basal inferior walls. In contrast, we observed
a much higher specificity and positive predictive value with
MCDSE (Table 1). With regard to test outcomes, McNemar’s
test showed that there were significant differences between
MCDSE and TST (p  0.05) and between MCDSE and MPS
(p  0.011).
This is the first prospective study to investigate the prevalence of
occult CAD in “apparently healthy” individuals who present with
ischemic type ST-segment depression during an episode of AF
that is not related to an acute cardiopulmonary event. In clinical
practice, it is common for such patients to proceed to coronary
arteriography, because: 1) this presentation is considered to be a
“positive stress test equivalent,” and 2) there are no data on the
diagnostic accuracy of the available noninvasive diagnostic tests in
this population. Current guidelines recommend that patients with
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AF and suspected myocardial ischemia should undergo TST (5).
However, there are no specific recommendations for patients with
characteristics similar to our study subjects. These patients are not
uncommon in everyday practice, and their proper management is
often a challenge. Our findings shed some light on this issue and
indicate that, in this setting, ST-segment changes are not consis-
tently associated with the presence of obstructive CAD, given that
approximately only 1 of 3 patients had angiographically significant
coronary lesions. Also, multivessel disease was not frequent in
those patients with CAD. In addition, it seems that MCDSE has
a high ability to discriminate significant CAD in these patients. In
contrast, MPS had a high rate of false positive defects and thus a
low specificity for CAD diagnosis. Atrial fibrillation might alter
membrane function in vascular endothelial cells and cardiomyo-
cytes, and this might have accounted, at least partly, for the high
rate of false positive MPS tests in our population. Accordingly, it
seems reasonable for patients with the aforementioned specific
clinical presentation to be risk stratified by a noninvasive stress test,
preferably MCDSE, rather than proceeding directly to coronary
angiography.
We should acknowledge a limitation of this study. Most
patients visited the hospital because of AF-related symptoms
(palpitations, chest discomfort, dyspnea). Among the eligible
patients, only 1 of 5 (83 of 407) completed the study. So, it is
possible that the prevalence of CAD in our population has been
overestimated, because of inclusion bias (i.e., patients with more
severe symptoms might have had a higher probability to accept
enrolment in the study).
In conclusion, in a population of patients without a history of
cardiovascular disease, we found that there is no strong association
between transient ischemic type ST-segment depression during
paroxysms of AF and underlying occult CAD.
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Figure 1 Schematic Flow Chart of the Study
AF  atrial fibrillation; CAD  coronary artery disease;
ECG  electrocardiogram; pts  patients; SR  sinus rhythm.
Diagnostic Performance of Noninvasive Stress Tests for Predicting CAD
Table 1 Diagnostic Performance of Noninvasive Stress Tests for Predicting CAD
Treadmill Stress Test*
Thallium-201 Myocardial
Scintigraphy
Myocardial Contrast Stress
Echocardiography
Patients with CAD (/ for ischemia) (n  27) 18/6 23/4 24/3
Patients without CAD (/ for ischemia) (n  56) 21/27 23/33 7/49
Sensitivity, % (95% CI) 75.0 (53.3–90.2) 85.2 (66.3–95.8) 88.9 (70.8–97.6)
Specificity, % (95% CI) 56.3 (41.2–70.5) 58.9 (45.0–71.9) 87.5 (75.9–94.8)
PPV, % (95% CI) 46.2 (30.1–62.8) 50.0 (34.9–65.1) 77.4 (58.9–90.4)
NPV, % (95% CI) 81.8 (65.4–93.0) 89.2 (74.6–97.0) 94.2 (84.1–98.8)
The 95% confidence intervals (CIs) were calculated from the binomial distribution. *For treadmill stress test, total n  72 (11 patients were unable to exercise).
CAD  coronary artery disease; NPV  negative predictive value; PPV  positive predictive value.
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Letters to the Editor
Coenzyme Q10
in Statin-Associated Myopathy
The excellent review by Macroff and Thompson titled “The role of
coenzyme Q10 on statin-associated myopathy” (1) concludes that
insufficient evidence exists for supplementation to treat or prevent
myopathy.
However, the authors recommend its use “if only via placebo
effect.” Should we not first be certain that statin-induced inhibition
of the farnesyl (and dolichol) pathways does not contribute to the
many pleiotropic benefits of statins before we attempt to “correct”
them?
*Harvey Wolinsky, MD, PhD, FACC
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Reply
Dr. Wolinsky raises an interesting issue. Statins block the rate-
limiting enzyme in the mevalonate pathway reducing cholesterol
production, but also reduce production of farnesyl and geranyl-
geranyl pyrophosphate. These molecules participate in post-
translational modification or prenylation of the Ras superfamily
guanosine triphosphatases or small G proteins. Small G proteins
are involved in cell signaling and proliferation. Statin inhibition of
these G proteins decreases vascular smooth muscle hypertrophy
and proliferation, improves endothelial function, and reduces
angiotensin I receptor expression (1). It may also explain the statin
antiarrhythmic effect in atrial fibrillation (2).
Coenzyme Q10 (Q10) supplementation should not affect small
G protein production since Q10 is not involved in the G protein
prenylation process. Furthermore, we recommended that Q10
supplementation be “tested” or “trialed” (3) only in statin myalgic
patients to allow ongoing statin treatment.
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Can Critically Short
Telomeres Cause Functional
Exhaustion of Progenitor Cells
in Postinfarction Heart Failure?
With great interest we read the article of Kissel et al. (1) on the
selective functional exhaustion of progenitor cells in patients with
ischemic cardiomyopathy (ICM) compared with nonischemic
dilated cardiomyopathy. As stated by the authors, obviously this
clinical study cannot disclose the potential mechanisms underlying
the functional impairment of progenitor cells. However, circum-
stantial evidence for a very reasonable explanation for the selective
exhaustion of (progenitor) cells in ICM could have been easily
obtained. Cells with telomeres reaching a critical length become
genomically unstable, become apoptotic, or enter replicative senes-
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